SEC Form 4 · accession 0001562180-16-003114
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Stambaugh
Officer — VP Clinical Affairs
Period of report
Sep 2, 2016
Accepted (ET)
Sep 7, 2016 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2016 | S | 300 | $16.00 | D | 23,700 | D | |
| Common Stock | Sep 6, 2016 | S | 3,700 | $16.00 | D | 20,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2016.